Alexis Guédon: Cardiovascular Risk Profiles and Outcomes in Patients With Giant Cell Arteritis
Alexis Guédon, Junior Deputy Editor at the European Journal of Preventive Cardiology, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
“I’m very happy to announce that our latest research article has just been published online ahead of print in the European Journal of Preventive Cardiology!
In this large nationwide cohort study, we examined the cardiovascular risk profiles and outcomes of patients with Giant Cell Arteritis (GCA) compared to matched control populations. Our findings highlight significantly increased risks of MACE, aortic, peripheral arterial, and visceral artery events in GCA patients – underscoring the critical importance of cardiovascular risk management and inflammation control in this population.
Key insights include:
- GCA is associated with elevated risk of major vascular complications.
- Disease activity is associated with major adverse cardiovascular events, highlighting the role of systemic inflammation.
Many thanks to all co-authors and collaborators who made this work possible!
Article: Cardiovascular risk among Giant cell arteritis patients
Authors: Alexis F Guedon, Olivier Espitia, Maxime Beydon, Etienne Ghrenassia, Tristan Mirault, Emmanuel Messas, Florence Tubach, Raphaèle Seror, Franck Boccara, Ariel Cohen, Ruth Frikke-Schmidt, Børge Grønne Nordestgaard, Azeddine Dellal, Olivier Fain, Arsène Mekinian, Fabrice Carrat
Read the Full Article on European Journal of Preventive Cardiology”
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 24, 2026, 17:12Ron DePinho: CRISPR Progress in Cellular Immunotherapy
-
Mar 24, 2026, 17:12Martine Gilard։ Women’s Heart Health as a National Priority
-
Mar 24, 2026, 17:11Erik Nelson։ Blood Vessels – The Silent System That Determines How You Age
-
Mar 24, 2026, 17:10Anthony Yazbeck: Why the Hemolysin Test Matters More Than You Think
-
Mar 24, 2026, 17:09Marcos Gamboa Chele: Are We Asking for Too Many Thrombophilia Panels?
-
Mar 24, 2026, 17:06Anita Brikman: PPTA Explores India’s Growing Plasma-Derived Medicines Industry
-
Mar 24, 2026, 17:01Victor Canata: Is Embolectomy the Best Treatment for Pulmonary Thromboembolism?
-
Mar 24, 2026, 16:57Hossam Qassem: The Stepwise Investigation Framework for ICU Hemoglobin Drop
-
Mar 24, 2026, 16:56Alan Nurden: Targeting Splice Site Variants in Alport Syndrome with Antisense Therapy